Clinical Research Directory
Browse clinical research sites, groups, and studies.
Asymmetrical HFNCO vs Standard HFNCO Post Cardiac Surgery Patients
Sponsor: National and Kapodistrian University of Athens
Summary
High-flow oxygen therapy has been applied after extubation in cardiac surgery patients with a well-known successful efficacy. The current authors plan to conduct a prospective, randomized, controlled study of the Asymmetrical device Nasal Cannula High Flow Oxygenation (HFNCO) application on high flow (60L/min) with 60% fiO2 administration versus Conventional device Nasal Cannula High Flow Oxygenation (HFNCO) application on high flow (60L/min) with 60% fiO2 administration and versus Conventional oxygen treatment (Venturi mask) after extubation of patients undergoing elective or non-elective cardiac surgery.
Official title: Study of Asymmetrical High Flow Nasal Cannula Oxygenation (HFNCO) vs Standard HFNCO on Cardiac Surgical Patients Postoperatively
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
63
Start Date
2024-05-01
Completion Date
2026-12-31
Last Updated
2026-03-17
Healthy Volunteers
No
Conditions
Interventions
Asymmetrical High Flow Nasal Cannula Oxygenation
Asymmetrical High Flow Nasal Cannula Oxygenation will be implemented in this study group. (1st study group, 60l/min airflow, 60% fiO2)
Conventional High Flow Nasal Cannula Oxygenation
Conventional High Flow Nasal Cannula Oxygenation will be implemented in this study group. (2nd study group, 60l/min airflow, 60% fiO2)
Locations (1)
Evangelismos General Hospital of Athens
Athens, Attica, Greece